Inventor
HOFFMANN PATRICK
DE40 patents
⚠️ This page may combine multiple inventors who share the name “HOFFMANN PATRICK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AMGEN RES MUNICH GMBH
32 patentsUS9340621B2May 17, 2016
Binding molecules for BCMA and CD3
AMGEN RES MUNICH GMBH91 citations98
US10294300B2May 21, 2019
Antibody constructs for DLL3 and CD3
AMGEN RES MUNICH GMBH37 citations97
US9150664B2Oct 6, 2015
Binding molecules for BCMA and CD3
AMGEN RES MUNICH GMBH64 citations97
US10301391B2May 28, 2019
BCMA and CD3 bispecific T cell engaging antibody constructs
AMGEN RES MUNICH GMBH28 citations93
US9598500B2Mar 21, 2017
Binding molecules for BCMA and CD3
AMGEN RES MUNICH GMBH22 citations93
US10519241B2Dec 31, 2019
Antibody constructs for EGFRVIII and CD3
AMGEN RES MUNICH GMBH16 citations92
US9688760B2Jun 27, 2017
Anti-leukocyte adhesion for the mitigation of potential adverse events caused by CD3-specific binding domains
AMGEN RES MUNICH GMBH17 citations90
US11591396B2Feb 28, 2023
Antibody constructs for DLL3 and CD3
AMGEN RES MUNICH GMBH5 citations85
US10752694B2Aug 25, 2020
Binding molecules for BCMA and CD3
AMGEN RES MUNICH GMBH11 citations85
US10766969B2Sep 8, 2020
Binding molecules for BCMA and CD3
AMGEN RES MUNICH GMBH8 citations83
US10683351B2Jun 16, 2020
Antibody constructs for DLL3 and CD3
AMGEN RES MUNICH GMBH4 citations83
US10781264B2Sep 22, 2020
PSMA and CD3 bispecific T cell engaging antibody constructs
AMGEN RES MUNICH GMBH8 citations82
US10059766B2Aug 28, 2018
Antibody constructs for CDH19 and CD3
AMGEN RES MUNICH GMBH9 citations82
US11661462B2May 30, 2023
Optimized cross-species specific bispecific single chain antibody contructs
AMGEN RES MUNICH GMBH4 citations73
US11434302B2Sep 6, 2022
Bispecific T cell engaging antibody constructs
AMGEN RES MUNICH GMBH7 citations73
US11472886B2Oct 18, 2022
Cross-species-specific PSMAxCD3 bispecific single chain antibody
AMGEN RES MUNICH GMBH3 citations71
US11352433B2Jun 7, 2022
BCMA and CD3 bispecific T cell engaging antibody constructs
AMGEN RES MUNICH GMBH2 citations71
US11155629B2Oct 26, 2021
Method for treating glioblastoma or glioma with antibody constructs for EGFRVIII and CD3
AMGEN RES MUNICH GMBH2 citations71
US11084876B2Aug 10, 2021
Anti-leukocyte adhesion for the mitigation of potential adverse events caused by CD3-specific binding domains
AMGEN RES MUNICH GMBH4 citations71
US9486475B2Nov 8, 2016
PPS for the prevention of potential adverse effects caused by CD3 specific binding domains
AMGEN RES MUNICH GMBH4 citations71
US11447567B2Sep 20, 2022
Antibody constructs for FLT3 and CD3
AMGEN RES MUNICH GMBH4 citations69
US10851170B2Dec 1, 2020
Antibody constructs for CD70 and CD3
AMGEN RES MUNICH GMBH3 citations67
US12435139B2Oct 7, 2025
Antibody constructs for DLL3 and CD3
AMGEN RES MUNICH GMBH0 citations62
US12304952B2May 20, 2025
Antibody constructs for DLL3 and CD3
AMGEN RES MUNICH GMBH0 citations62
US11987633B2May 21, 2024
Cross-species-specific single domain bispecific single chain antibody
AMGEN RES MUNICH GMBH1 citations62
US12428491B2Sep 30, 2025
PSMA and CD3 bispecific T cell engaging antibody constructs
AMGEN RES MUNICH GMBH0 citations61
US12152078B2Nov 26, 2024
Nucleic acids encoding anitbody constructs binding EGFR VIII and CD3
AMGEN RES MUNICH GMBH0 citations61
US11498964B2Nov 15, 2022
Antibody constructs for CDH19 and CD3
AMGEN RES MUNICH GMBH1 citations61
US12281172B2Apr 22, 2025
Cross-species-specific PSMAxCD3 bispecific single chain antibody
AMGEN RES MUNICH GMBH0 citations60
US11884720B2Jan 30, 2024
Antibody constructs for MSLN and CD3
AMGEN RES MUNICH GMBH1 citations60
US11926666B2Mar 12, 2024
Bispecific antibody constructs for CDH3 and CD3
AMGEN RES MUNICH GMBH0 citations57
US11028171B2Jun 8, 2021
Bispecific antibody constructs for CDH3 and CD3
AMGEN RES MUNICH GMBH1 citations57
AMGEN INC
5 patentsUS9765157B2Sep 19, 2017
Antibody constructs for CDH19 and CD3
AMGEN INC13 citations82
US12281176B2Apr 22, 2025
Binding molecules for BCMA and CD3
AMGEN INC1 citations74
US12297292B2May 13, 2025
Antibody constructs for CDH19 and CD3
AMGEN INC2 citations72
US12281175B2Apr 22, 2025
Binding molecules for BCMA and CD3
AMGEN INC0 citations62
US12441796B2Oct 14, 2025
Antibody constructs for CDH19 and CD3
AMGEN INC0 citations61